BVS
HealthcareBioventus Inc - Class A
$10.92+0.24 (+2.25%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving BVS Today?
No stock-specific AI insight has been generated for BVS yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$739M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding67.6M
BVS News
20 articles- Wall Street Analysts See a 38.97% Upside in Bioventus (BVS): Can the Stock Really Move This High?Yahoo Finance·May 8, 2026
- Bioventus Inc. Q1 2026 Earnings Call SummaryMoby·May 6, 2026
- Bioventus (BVS) Q1 2026 Earnings TranscriptMotley Fool·May 6, 2026
- Bioventus Q1 Earnings Call HighlightsMarketbeat·May 6, 2026
- Bioventus (BVS) Surpasses Q1 Earnings and Revenue EstimatesYahoo Finance·May 6, 2026
- Bioventus Reports First Quarter Financial ResultsYahoo Finance·May 6, 2026
- Should Value Investors Buy Bioventus (BVS) Stock?Yahoo Finance·May 5, 2026
- TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 RevenuesYahoo Finance·Apr 30, 2026
- Are Investors Undervaluing Amneal Pharmaceuticals (AMRX) Right Now?Yahoo Finance·Apr 29, 2026
- Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026Yahoo Finance·Apr 28, 2026
- Strength Seen in Bioventus (BVS): Can Its 6.6% Jump Turn into More Strength?Yahoo Finance·Apr 16, 2026
- ASX Penny Stocks To Watch In April 2026Yahoo Finance·Apr 14, 2026
- Are Investors Undervaluing Bioventus (BVS) Right Now?Yahoo Finance·Apr 13, 2026
- How The Bravura Solutions (ASX:BVS) Story Is Shifting On Earnings Guidance And Dividend MovesYahoo Finance·Mar 26, 2026
- Bioventus Q4 Earnings Call HighlightsMarketbeat·Mar 5, 2026
- Bioventus Inc (BVS) Q4 2025 Earnings Call Highlights: Strong Organic Growth and Strategic ...Yahoo Finance·Mar 5, 2026
- Bioventus Inc. Q4 2025 Earnings Call SummaryMoby·Mar 5, 2026
- Bioventus (BVS) Q4 2025 Earnings Call TranscriptMotley Fool·Mar 5, 2026
- Bioventus: Q4 Earnings SnapshotYahoo Finance·Mar 5, 2026
- Bioventus Announces Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Mar 5, 2026
All 20 articles loaded
Price Data
Open$10.18
Previous Close$10.68
Day High$10.73
Day Low$10.12
52 Week High—
52 Week Low—
Fundamentals
Market Cap$739M
P/E Ratio—
EPS—
Dividend Yield—
Dividend / Share—
ROE—
Profit Margin—
Debt / Equity—
Trading
Volume1.1M
Avg Volume (10D)—
Shares Outstanding67.6M
About Bioventus Inc - Class A
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.
HealthcareSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Company Details
Security TypeStock
ExchangeNASDAQ
Currency—
Round Lot—
SICSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CIK—
Composite FIGI—
Share Class FIGI—